Sociobehavioural and clinical characteristics of the study population (n=4341)
| Characteristics | With anogenital HSV-related ulcers (n=425) | No HSV-related ulcers (n=3916) | P value |
| Age at baseline* | 39.3 (31.7–46.0) | 41.1 (31.8–48.8) | 0.006 |
| Age at HIV diagnosis* | 30.1 (24.8–36.9) | 33.3 (26.5–41.3) | <0.0001 |
| Age at HAUD* | 43.1 (35.2–50.4) | -- | |
| Race | 0.167 | ||
| Black | 262 (61.7) | 2318 (59.2) | |
| White | 153 (36.0) | 1435 (36.6) | |
| Others | 10 (2.3) | 163 (4.2) | |
| Median years of follow-up | 2.9 (0.8–6.1) | 4.6 (2.2–8.5) | <0.0001 |
| Gender | <0.0001 | ||
| Male | 273 (64.2) | 3060 (78.14) | |
| Female | 151 (35.5) | 834 (21.30) | |
| Transgender | 1 (0.3) | 22 (0.56) | |
| HIV risk factors | 0.044 | ||
| MSM | 207 (49.0) | 2030 (53.4) | |
| Heterosexual | 187 (44.2) | 1431 (37.6) | |
| IVDU | 29 (0.68) | 336 (8.8) | |
| Others | 0 (0.0) | 6 (0.2) | |
| Log10 VL (copies/mL)† | 4.8 (5.2) | 4.7 (5.3) | 0.23 |
| NadirCD4 (cells/μL)* | 250 (53–453) | 279 (100–451) | 0.17 |
*Median (IQR 25%–75%) is reported.
†Mean (SD) is reported.
EHR, eletronic health records; HAUD, herpetic anogenital ulcer disease; IVDU, intravenous drug users; MSM, men who have sex with men; VL, viral load.